Beibei Ni, Yanying Liu, Meng Dai, Jun Zhao, Yu Liang, Xue Yang, Bing Han & Man Jiang. (2023) The role of cannabidiol in aging. Biomedicine & Pharmacotherapy 165, pages 115074.
Crossref
Meenu Minhas & Stephanie E. Lunn. (2023) Naturalistic examination of the anxiolytic effects of medical cannabis and associated gender and age differences in a Canadian cohort. Journal of Cannabis Research 5:1.
Crossref
Elise A Schubert, Johannes C Alffenaar, Masego T Johnstone, John W Barlow & Nial J Wheate. (2023) Medicinal cannabis for patients with chronic non-cancer pain: analysis of safety and concomitant medications. International Journal of Pharmacy Practice 31:1, pages 70-79.
Crossref
Maria T Rivera-Garcia, Rizelle Mae Rose & Adrianne R Wilson-Poe. (2023) High-CBD Cannabis Vapor Attenuates Opioid Reward and Partially Modulates Nociception in Female Rats. Addiction Neuroscience 5, pages 100050.
Crossref
Caroline A. MacCallum, April L. Christiansen, Lindsay A. Lo, Carly A. Pistawka, Michael Boivin & Melissa Snider-Adler. 2023. Medicinal Usage of Cannabis and Cannabinoids. Medicinal Usage of Cannabis and Cannabinoids
229
243
.
Giada Crescioli, Valentina Maggini, Fabio Firenzuoli, Alfredo Vannacci & Niccolò Lombardi. 2023. Medicinal Usage of Cannabis and Cannabinoids. Medicinal Usage of Cannabis and Cannabinoids
135
145
.
David A. Campos, Edgar J. Mendivil, Mario Romano, Mariano García & Miriam E. Martínez. (2022) A Systematic Review of Medical Cannabinoids Dosing in Human. Clinical Therapeutics 44:12, pages e39-e58.
Crossref
Jag H. Khalsa, Gregory Bunt, Kenneth Blum, Sanjay B. Maggirwar, Marc Galanter & Marc N. Potenza. (2022) Review: Cannabinoids as Medicinals. Current Addiction Reports 9:4, pages 630-646.
Crossref
Majd Al-Soleiti, Kayla Balaj, Robyn P. Thom, Christopher J. McDougle & Christopher J. Keary. (2021) Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders 52:9, pages 4164-4171.
Crossref
Ralph-Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, Mohammad-Ali Jenabian & Cecilia T. Costiniuk. (2022) Cannabinoids and Chronic Liver Diseases. International Journal of Molecular Sciences 23:16, pages 9423.
Crossref
Elisabeth Philips, Simon Erridge & Mikael H Sodergren. (2022) Cannabis-based medicinal products: a clinical guide. British Journal of Neuroscience Nursing 18:4, pages 170-174.
Crossref
Arsène Zongo, Cerina Lee, Jihane El-Mourad, Jason R. B. Dyck, Elaine Hyshka, John G. Hanlon & Dean T. Eurich. (2021) Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study. The Canadian Journal of Psychiatry 67:7, pages 544-552.
Crossref
Maša Knehtl, Tadej Petreski, Nejc Piko, Robert Ekart & Sebastjan Bevc. (2022) Polypharmacy and Mental Health Issues in the Senior Hemodialysis Patient. Frontiers in Psychiatry 13.
Crossref
Anna E. Kirkland, Matthew C. Fadus, Staci A. Gruber, Kevin M. Gray, Timothy E. Wilens & Lindsay M. Squeglia. (2022) A scoping review of the use of cannabidiol in psychiatric disorders. Psychiatry Research 308, pages 114347.
Crossref
Leticia Shea. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1489
1518
.
Leticia Shea. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
33
.
Margaret-Ann Tait, Daniel S J Costa, Rachel Campbell, Richard Norman, Stephan Schug & Claudia Rutherford. (2021) A Quality-of-Life Evaluation Study Assessing Health-Related Quality of Life in Patients Receiving Medicinal Cannabis (the QUEST Initiative): Protocol for a Longitudinal Observational Study. JMIR Research Protocols 10:11, pages e32327.
Crossref
Lyndsey L. Anderson, Peter T. Doohan, Lachlan Oldfield, Richard C. Kevin, Jonathon C. Arnold, Maximus Berger, G. Paul Amminger & Iain S. McGregor. (2021) Citalopram and Cannabidiol. Journal of Clinical Psychopharmacology 41:5, pages 525-533.
Crossref
Christian Lizette Frías-Soria, Daniel Pérez-Pérez, Sandra Orozco-Suárez & Luisa Rocha. (2021) Cannabidiol modifies the seizure expression and effects of antiseizure drugs in a rat model of recurrent severe seizures. Seizure 90, pages 67-73.
Crossref
Christopher Vierke, Brigitte Marxen, Michael Boettcher, Christoph Hiemke & Ursula Havemann-Reinecke. (2020) Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy. European Archives of Psychiatry and Clinical Neuroscience 271:5, pages 847-856.
Crossref
Sara Pisani, Katie McGoohan, Latha Velayudhan & Sagnik Bhattacharyya. (2021) Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies. Drugs & Aging.
Crossref
Caroline A. MacCallum, Lindsay A. Lo & Michael Boivin. (2021) “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations. European Journal of Internal Medicine 89, pages 10-18.
Crossref
Jason Wallach. 2021. Remington. Remington
75
101
.
Matthew Chung, Barlas Benkli, Salman Hirani & Christina Le-Short. 2021. Cannabinoids and Pain. Cannabinoids and Pain
211
220
.
Caroline A. MacCallum, Lindsay A. Lo & Michael Boivin. 2021. Cannabinoids and Pain. Cannabinoids and Pain
179
188
.
George Polson, Matthew Chung, Salman Hirani & Christina Le-Short. 2021. Cannabinoids and Pain. Cannabinoids and Pain
93
101
.
Leticia A. Shea, Megan Leeds, Doan Bui, Mayda Mujica, Marlee Poupard, Reyna Rodriguez, Janelle M. Matura, Anna Carnazzo & Allyson Spence. (2020) “Over-the-counter” cannabidiol (CBD) sold in the community pharmacy setting in Colorado. Drugs & Therapy Perspectives 36:12, pages 573-582.
Crossref
Daniela Amaral Silva, David W. Pate, Robert D. Clark, Neal M. Davies, Ayman O.S. El-Kadi & Raimar Löbenberg. (2020) Phytocannabinoid drug-drug interactions and their clinical implications. Pharmacology & Therapeutics 215, pages 107621.
Crossref
Margarita Zhelyazkova, Bogdan Kirilov & Georgi Momekov. (2020) The pharmacological basis for application of cannabidiol in cancer chemotherapy. Pharmacia 67:4, pages 239-252.
Crossref
Anastasia S. Suraev, Nathaniel S. Marshall, Ryan Vandrey, Danielle McCartney, Melissa J. Benson, Iain S. McGregor, Ronald R. Grunstein & Camilla M. Hoyos. (2020) Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies. Sleep Medicine Reviews 53, pages 101339.
Crossref
Ivan Urits, Kyle Gress, Karina Charipova, Kelly Habib, David Lee, Christopher Lee, Jai Won Jung, Hisham Kassem, Elyse Cornett, Antonella Paladini, Giustino Varrassi, Alan D. Kaye & Omar Viswanath. (2020) Use of cannabidiol (CBD) for the treatment of chronic pain. Best Practice & Research Clinical Anaesthesiology 34:3, pages 463-477.
Crossref
Paul T. Kocis & Kent E. Vrana. (2020) Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Medical Cannabis and Cannabinoids 3:1, pages 61-73.
Crossref
Marta Vázquez, Natalia Guevara, Cecilia Maldonado, Paulo Cáceres Guido & Paula Schaiquevich. (2020) Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain. BioMed Research International 2020, pages 1-9.
Crossref
Elizabeth StuytRichard L. Hilderbrand. (2020)
Re: “Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series” by Elms et al. (
J Altern Complement Med
2019;25:392–397. DOI: 10.1089/acm.2018.0437)
. The Journal of Alternative and Complementary Medicine 26:4, pages 349-350.
Crossref
Joshua L. Rein. (2020) The nephrologistʼs guide to cannabis and cannabinoids. Current Opinion in Nephrology and Hypertension 29:2, pages 248-257.
Crossref
Lauren Singer, Hannah Tokish, Faith Park, Christine Campisi & Ruth L. Milanaik. (2020) The cannabidiol conundrum: potential benefits and risks of cannabidiol products for children. Current Opinion in Pediatrics 32:1, pages 198-205.
Crossref
Leticia A. Shea, Micheline A. Goldwire, David Hymel & Doan Bui. (2020) Colorado community pharmacists’ survey and their perspectives regarding marijuana. SAGE Open Medicine 8, pages 205031212093821.
Crossref
Giada Crescioli, Niccolò Lombardi, Alessandra Bettiol, Francesca Menniti‐Ippolito, Roberto Da Cas, Maria Parrilli, Martina Del Lungo, Eugenia Gallo, Alessandro Mugelli, Valentina Maggini, Fabio Firenzuoli & Alfredo Vannacci. (2020) Adverse events following cannabis for medical use in Tuscany: An analysis of the Italian Phytovigilance database. British Journal of Clinical Pharmacology 86:1, pages 106-120.
Crossref
Jessica W. Skelley, Crystal M. Deas, Zachary Curren & Jonathan Ennis. (2020) Use of cannabidiol in anxiety and anxiety-related disorders. Journal of the American Pharmacists Association 60:1, pages 253-261.
Crossref
Karen E. Moeller, J. Michael McGuire & Brittany L. Melton. (2020) A nationwide survey of pharmacy students’ knowledge and perceptions regarding medical cannabis. Journal of the American Pharmacists Association 60:1, pages 218-224.e3.
Crossref
Vimal M. Aga, Mujeeb U. Shad, Hongru Zhu & Carl Salzman. 2020. Handbook of Mental Health and Aging. Handbook of Mental Health and Aging
315
399
.
Karan Mathur, Vahin Vuppalanchi, Kayla Gelow, Raj Vuppalanchi & Craig Lammert. (2019) Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis. Digestive Diseases and Sciences 65:1, pages 322-328.
Crossref
Richard L. Hilderbrand. 2020. Cannabis in Medicine. Cannabis in Medicine
3
23
.
Patrick Tapley & Suzanne Kellett. (2019) Cannabis-based medicines and the perioperative physician. Perioperative Medicine 8:1.
Crossref
Lindsey M. Philpot, Jon O. Ebbert & Ryan T. Hurt. (2019) A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Family Practice 20:1.
Crossref
Wessam H. Abd-Elsalam, Muhammad A. Alsherbiny, Janice Y. Kung, David W. Pate & Raimar Löbenberg. (2019) LC–MS/MS quantitation of phytocannabinoids and their metabolites in biological matrices. Talanta 204, pages 846-867.
Crossref
Brian C. Foster, Hanan Abramovici & Cory S. Harris. (2019) Cannabis and Cannabinoids: Kinetics and Interactions. The American Journal of Medicine 132:11, pages 1266-1270.
Crossref
Thorsten Rudroff. (2019) Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data. Frontiers in Pharmacology 10.
Crossref
Frank Petzke, Matthias Karst, Knud Gastmeier, Lukas Radbruch, Eva Steffen & Winfried Häuser. (2019) Ein Positionspapier zu medizinischem Cannabis und cannabisbasierten Medikamenten in der SchmerzmedizinPosition paper on medical cannabis and cannabis-based medicines in pain medicine. Der Schmerz 33:5, pages 449-465.
Crossref
Julie Zhu & Kevork M Peltekian. (2019) Cannabis and the liver: Things you wanted to know but were afraid to ask. Canadian Liver Journal 2:3, pages 51-57.
Crossref
Dana Barchel, Orit Stolar, Tal De-Haan, Tomer Ziv-Baran, Naama Saban, Danny Or Fuchs, Gideon Koren & Matitiahu Berkovitch. (2019) Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities. Frontiers in Pharmacology 9.
Crossref
Muhammad Alsherbiny & Chun Li. (2018) Medicinal Cannabis—Potential Drug Interactions. Medicines 6:1, pages 3.
Crossref
Sonja Vučković, Dragana Srebro, Katarina Savić Vujović, Čedomir Vučetić & Milica Prostran. (2018) Cannabinoids and Pain: New Insights From Old Molecules. Frontiers in Pharmacology 9.
Crossref
James S. Wheeler & Tracy M. Hagemann. (2018) Medical marijuana in the United States: Historical perspectives, legal considerations, and professional obligations of the pharmacist. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 1:1.
Crossref
Winfried Häuser, David P. Finn, Eija Kalso, Nevenka Krcevski-Skvarc, Hans-Georg Kress, Bart Morlion, Serge Perrot, Michael Schäfer, Chris Wells & Silviu Brill. (2018) European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. European Journal of Pain 22:9, pages 1547-1564.
Crossref
A. Suraev, N. Lintzeris, J. Stuart, R. C. Kevin, R. Blackburn, E. Richards, J. C. Arnold, C. Ireland, L. Todd, D. J. Allsop & I. S. McGregor. (2018) Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community. Scientific Reports 8:1.
Crossref